IDSA and HIVMA condemn the U.S. Supreme Court decision overturning Roe v. Wade that sanctions government interference in patient autonomy and care and threatens the sanctity of the provider-patient relationship.
IDSA and HIVMA condemn the U.S. Supreme Court decision overturning Roe v. Wade that sanctions government interference in patient autonomy and care and threatens the sanctity of the provider-patient relationship.
People who may be most in need of antiviral treatment for COVID-19 may not be receiving it because of where they live, according to a recent report from the U.S. Centers for Disease Control and Prevention.
IDSA supports the decision by the Food and Drug Administration and the Centers for Disease Control and Prevention to authorize the Pfizer-BioNTech and Moderna COVID-19 vaccines for young children and infants ages 5 years and younger.
IDSA in collaboration with CDC has selected 11 ID programs for the first Joint ID/CDC Epidemic Intelligence Service Fellowship. Each of the 11 programs will serve as options for the ID fellowship track for the joint IDSA and CDC training program.
IDSA and HIVMA echo the concern expressed by UNAIDS about the use of racist and homophobic language regarding the current monkeypox outbreak.
IDSA supports decisions by the Food and Drug Administration and the Centers for Disease Control and Prevention to recommend COVID-19 vaccine booster shots for children ages 5-11 who have already completed the two-shot primary series.
What was once unfathomable – one million people dying from COVID-19 -- is a reality that is difficult to comprehend. Infectious diseases experts throughout the nation mourn the immense loss of life.
The IDSA agrees with the Centers for Disease Control and Prevention’s recommendation that everyone wear well-fitting, high-quality masks in indoor public settings when COVID-19 community levels are high.
The official launch of the Centers for Disease Control and Prevention’s Center for Forecasting and Outbreak Analytics, which was created last summer, is a welcome step in our country’s fight against COVID-19 and future pandemics.
The Infectious Diseases Society of America has selected Ty Johnson, MBA, as its new chief operating officer, effective April 4. In this new role, Johnson will provide leadership across the organization to achieve IDSA’s strategic priorities.
IDSA is encouraged that the president’s budget request for FY 2023 includes significant new investment in key infectious diseases priorities to keep our nation healthy.
FDA’s authorization of a second COVID-19 booster shot for individuals 50 and over provides another opportunity for people to increase their level of protection against severe disease, hospitalization and death.